Moderna's (MRNA) BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants

Go back to Moderna's (MRNA) BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants

Moderna (MRNA) Extends Gain, Up 6.5%

November 14, 2022 12:06 PM EST

Moderna (NASDAQ: MRNA) Extends Gain, Up 6.5%

... More